×
Dual Reuptake Inhibitors Incur Lower Rates of Tachyphylaxis Than Selective Serotonin Reuptake Inhibitors: A Retrospective Study PDF
$ 40.00
Dual Reuptake Inhibitors Incur Lower Rates of Tachyphylaxis Than Selective Serotonin Reuptake Inhibitors: A Retrospective Study PDF quantity
$ 40.00
×
Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial PDF
$ 40.00
Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial PDF quantity
$ 40.00
×
Neurocognitive Impairment and Psychosis in Bipolar I Disorder During Early Remission From an Acute Episode of Mood Disturbance PDF
$ 40.00
Neurocognitive Impairment and Psychosis in Bipolar I Disorder During Early Remission From an Acute Episode of Mood Disturbance PDF quantity
$ 40.00
×
Differential Prescription of Maintenance Antipsychotics to African American and White Patients With New-Onset Bipolar Disorder PDF
$ 40.00
Differential Prescription of Maintenance Antipsychotics to African American and White Patients With New-Onset Bipolar Disorder PDF quantity
$ 40.00
×
Incidence of, Risk Factors for, and Changes Over Time in Treatment-Resistant Depression in Denmark: A Register-Based Cohort Study PDF
$ 40.00
Incidence of, Risk Factors for, and Changes Over Time in Treatment-Resistant Depression in Denmark: A Register-Based Cohort Study PDF quantity
$ 40.00
×
A Randomized Controlled Trial of Risperidone and Olanzapine for Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia PDF
$ 40.00
A Randomized Controlled Trial of Risperidone and Olanzapine for Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia PDF quantity
$ 40.00
×
Pharmacologic Treatment of Anxiety Disorders in 1989 Versus 1996: Results From the Harvard/Brown Anxiety Disorders Research Program PDF
$ 40.00
Pharmacologic Treatment of Anxiety Disorders in 1989 Versus 1996: Results From the Harvard/Brown Anxiety Disorders Research Program PDF quantity
$ 40.00
×
Pharmacoeconomic Analysis of Sertraline Treatment of Depression in Patients With Unstable Angina or a Recent Myocardial Infarction PDF
$ 40.00
Pharmacoeconomic Analysis of Sertraline Treatment of Depression in Patients With Unstable Angina or a Recent Myocardial Infarction PDF quantity
$ 40.00
×
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in Children and Adolescents With Tourette's Disorder PDF
$ 40.00
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in Children and Adolescents With Tourette's Disorder PDF quantity
$ 40.00
×
Impact of a US Food and Drug Administration Drug Safety Communication on Zolpidem Dosing: An Observational Retrospective Cohort PDF
$ 40.00
Impact of a US Food and Drug Administration Drug Safety Communication on Zolpidem Dosing: An Observational Retrospective Cohort PDF quantity
$ 40.00
×
Vardenafil in the Treatment of Erectile Dysfunction in Outpatients With Chronic Schizophrenia: A Flexible-Dose, Open-Label Study PDF
$ 40.00
Vardenafil in the Treatment of Erectile Dysfunction in Outpatients With Chronic Schizophrenia: A Flexible-Dose, Open-Label Study PDF quantity
$ 40.00
×
An Open-Label Trial of Topiramate in the Treatment of Skin Picking in Pervasive Developmental Disorder Not Otherwise Specified PDF
$ 40.00
An Open-Label Trial of Topiramate in the Treatment of Skin Picking in Pervasive Developmental Disorder Not Otherwise Specified PDF quantity
$ 40.00
×
Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in Switzerland PDF
$ 40.00
Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in Switzerland PDF quantity
$ 40.00
×
Responses to the Medical Review of Systems: Borderline Versus Nonborderline Patients in an Internal Medicine Outpatient Clinic PDF
$ 40.00
Responses to the Medical Review of Systems: Borderline Versus Nonborderline Patients in an Internal Medicine Outpatient Clinic PDF quantity
$ 40.00
×
Cognitive Rehabilitation and Exposure/Sorting Therapy (CREST) for Hoarding Disorder in Older Adults: A Randomized Clinical Trial PDF
$ 40.00
Cognitive Rehabilitation and Exposure/Sorting Therapy (CREST) for Hoarding Disorder in Older Adults: A Randomized Clinical Trial PDF quantity
$ 40.00
×
Risk of Cerebrovascular Adverse Events in Older Adults Using Antipsychotic Agents: A Propensity-Matched Retrospective Cohort Study PDF
$ 40.00
Risk of Cerebrovascular Adverse Events in Older Adults Using Antipsychotic Agents: A Propensity-Matched Retrospective Cohort Study PDF quantity
$ 40.00
×
Cigarette Use and Cannabis Use Disorder Onset, Persistence, and Relapse: Longitudinal Data From a Representative Sample of US Adults PDF
$ 40.00
Cigarette Use and Cannabis Use Disorder Onset, Persistence, and Relapse: Longitudinal Data From a Representative Sample of US Adults PDF quantity
$ 40.00
×
A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia PDF
$ 40.00
A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia PDF quantity
$ 40.00
×
A Randomized, Double-Blind, Fixed-Dose Comparison of Paroxetine and Placebo in the Treatment of Generalized Social Anxiety Disorder PDF
$ 40.00
A Randomized, Double-Blind, Fixed-Dose Comparison of Paroxetine and Placebo in the Treatment of Generalized Social Anxiety Disorder PDF quantity
$ 40.00
×
Appetitive Symptoms Differentially Predict Treatment Response to Fluoxetine, Light, and Placebo in Nonseasonal Major Depression PDF
$ 40.00
Appetitive Symptoms Differentially Predict Treatment Response to Fluoxetine, Light, and Placebo in Nonseasonal Major Depression PDF quantity
$ 40.00
×
Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder PDF
$ 40.00
Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder PDF quantity
$ 40.00
×
Experiential Avoidance Predicts Persistence of Major Depressive Disorder and Generalized Anxiety Disorder in Late Adolescence PDF
$ 40.00
Experiential Avoidance Predicts Persistence of Major Depressive Disorder and Generalized Anxiety Disorder in Late Adolescence PDF quantity
$ 40.00
×
Comparative Effects of Mirtazapine and Fluoxetine on Sleep Physiology Measures in Patients With Major Depression and Insomnia PDF
$ 40.00
Comparative Effects of Mirtazapine and Fluoxetine on Sleep Physiology Measures in Patients With Major Depression and Insomnia PDF quantity
$ 40.00
×
New-Onset Seizures and Psychosis in an Elderly Patient With No Seizure History in the Context of Low-Dose Diazepam Withdrawal PDF
$ 40.00
New-Onset Seizures and Psychosis in an Elderly Patient With No Seizure History in the Context of Low-Dose Diazepam Withdrawal PDF quantity
$ 40.00
×
Possible Link Between Childhood Separation Anxiety and Adulthood Personality Disorder in Patients With Anxiety Disorders in Japan PDF
$ 40.00
Possible Link Between Childhood Separation Anxiety and Adulthood Personality Disorder in Patients With Anxiety Disorders in Japan PDF quantity
$ 40.00
×
Treatment of Depression With Methylphenidate in Patients Difficult to Wean From Mechanical Ventilation in the Intensive Care Unit PDF
$ 40.00
Treatment of Depression With Methylphenidate in Patients Difficult to Wean From Mechanical Ventilation in the Intensive Care Unit PDF quantity
$ 40.00
×
Mirtazapine: Efficacy and Tolerability in Comparison With Fluoxetine in Patients With Moderate to Severe Major Depressive Disorder PDF
$ 40.00
Mirtazapine: Efficacy and Tolerability in Comparison With Fluoxetine in Patients With Moderate to Severe Major Depressive Disorder PDF quantity
$ 40.00
×
Switching From Clozapine to Olanzapine in Treatment-Refractory Schizophrenia: Safety, Clinical Efficacy, and Predictors of Response PDF
$ 40.00
Switching From Clozapine to Olanzapine in Treatment-Refractory Schizophrenia: Safety, Clinical Efficacy, and Predictors of Response PDF quantity
$ 40.00
×
"Subthreshold" Depression: Is the Distinction Between Depressive Disorder Not Otherwise Specified and Adjustment Disorder Valid? PDF
$ 40.00
"Subthreshold" Depression: Is the Distinction Between Depressive Disorder Not Otherwise Specified and Adjustment Disorder Valid? PDF quantity
$ 40.00
×
Sexual Dysfunction in Male Subjects Receiving Trifluoperazine, Risperidone, or Olanzapine: Rates Vary With Assessment Questionnaire PDF
$ 40.00
Sexual Dysfunction in Male Subjects Receiving Trifluoperazine, Risperidone, or Olanzapine: Rates Vary With Assessment Questionnaire PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
